Search Results

Why receptor localization and scaffolding dramatically shift functional readouts in disease models. validation under real experimental constraints, Tried to map signaling heterogeneity in disease-relevant models

Clear Platform Assessment: Gain rapid, independent insight into GPCR platform risks and true therapeutic Organizations Elevate Scientific Offerings: Refine and optimize your GPCR assay platforms and in vitro models We made confident progress on a pivotal program and gained clarity on our next strategic focus.

Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule A positive Allosteric Modulator

Signaling Trafficking Metabolism Structure and Bioinformatics Health and Disease Immunology Nervous system Model

My initial focus was on creating an automated chimeric homology modeling pipeline for GPCRs and since

My initial focus was on creating an automated chimeric homology modeling pipeline for GPCRs and since

studied receptor function in human physiology, receptor molecular pharmacology in cells, and animal models

California in San Francisco to continue his training as a postdoctoral researcher where he used structural models

transmembrane receptors, combining biochemical and structural approaches with cell biology and in vivo models

His research group uses a combination of pharmacological investigations and mathematical modeling to

He adapts interdisciplinary approaches (synthesis, modeling, pharmacology) to study G protein-coupled

the understanding of how an orphan GPCR exerts its effects both in vitro (cell culture and ex vivo models

Overall, the lab works on diverse models and diseases, and has developed a wide array of tools to dissect

computational structural biology tools and rational drug design approaches, ranging from molecular modeling

laboratory is to understand the physiological consequences of NMDA receptor deficiency using genetic mouse models

the role of RGS4 and RGS5 in airway hyperresponsiveness and lung fibrosis in acute and chronic mouse models A fungal serine protease allergen with GPCR-modulating features was discovered as a new biomarker and

mechanism through which rare genetic variation may lead to or protecting from excessive body weight gain Yamina will schedule a future talk with Jacek about GPCRs as therapeutic modalities. The discussion revealed their interest in GPCRs as therapeutic modalities and possible future collaborations

Mikel Garcia-Marcos "I was trained as a biochemist and molecular biologist during my Ph.D (2005) in Spain (biochemistry, cell biology, genetics) and experimental systems (purified proteins, cultured cells, model Garcia-Marcos's academic journey, which spans training in Spain, Belgium, and a postdoctoral fellowship

CD97 in glioblastoma Dimitris Placantonakis Adhesion G protein-coupled receptor latrophilin-3 (ADGRL3) modulation out Ryk, required for Vangl2 function, protected synapses and preserved cognitive function in a mouse model Collectively, these data suggest that ADCs targeting CD97 impair tumor growth in preclinical GBM models Placantonakis Lab Google Scholar LinkedIn Adhesion G protein-coupled receptor latrophilin-3 (ADGRL3) modulation

There she focused on the different modes of action of Adhesion GPCRs and found that they do not only different signals on a molecular level and how these are translated into physiological functions in various model

Slosky characterized a new class of β-arrestin biased allosteric modulators (BAMs) for the neurotensin Critically, these ligands reduce addiction-associated behaviors in animal models without the side effects

📌 Measuring Bias: A Quantitative Approach 🔹 The operational model provides a structured way to measure

De-risk decisions: gain expert strategic guidance on study design, timelines, and partner selection before credible GPCR CROs and expert consultants 📚 Train and upskill your team with specialized programs 📢 Gain Gain confidence and direction with a customized roadmap aligned to your biotech’s goals and timeline Gain clarity and direction to move your biotech forward—faster and smarter. → Explore Timeline Strategy

validation in GPCR assay design Building reagents that must work in complex tissues, not just simplified models chemistry from the University of Bari in 2018, including research training at the CIQUS Research Center in Spain Her work centers on GPCR modulators, synthetic chemistry, and enabling robust biological assays through

Working in a lab allows scientists to gain amazing hard and soft skills, which opens the doors to several

She has gained experience from working in academia and at GSK as an industrial trainee.

My main topics were protein biochemistry, Drosophila husbandry, and genetics. Since then, I have broadened my horizons with many more techniques in vivo and in vitro, with a main

and his team are working on understanding receptor signaling in specialized cellular environments to gain

Receptors and Hearing and Balance Receptors Bill Huang Self-Cleavage of GPR110 SEA Domain and Its Impact on GAIN adhesion GPCR Signaling and Pharmacology-Enabling Drug Discovery Fabian Pohl Structural Determinants Of GAIN Caroline Formstone Interrogating The Role Of CELSR1 (ADGRC1) In Breast Cancer Mariam Melkumyan GPR110 modulates TNIK Sumit Bandekar Structural studies of the CELSR1 extracellular region reveal a compact multidomain module regulates signaling Nicole Perry-Hauser Adhesion G protein-coupled receptor latrophilin-3 (ADGRL3) modulation

structural biology, pharmacology, and pharmacoepidemiology with innovative computational methods to gain